- Researchers and health professionals gain a deeper understanding of the functional effects of tumour heterogeneity during cancer initiation and progression, supporting the identification of more precise and novel therapeutic targets. - Researchers, health professionals and innovators benefit from improved knowledge and tools to support the discovery and development of next generation genomically-informed cancer treatments.
The conditions for qualifying. An eligibility check tests your details against each one.
At least 3 independent partners
Does your company qualify?
Give a few facts about your company and project, and see for each condition whether you meet it.
Eligibility checkGrant from URBAN PROSUMERS (EU-funded project) across the EU. Total budget €180,000. Applications until 30 September 2026.
- Complete Indicator Framework: A validated indicator framework of short-term actions, outcomes and long-term impacts, for both the ECS programme and the Chips for Europe Initiative, integr…
This topic is the first phase of a two-phase competitive structure supported by Horizon Europe, implemented via a Coordination and Support Action (CSA) in close collaboration with the Europ…
A check is an indication from the published conditions and the facts you give. Only the competent authority decides whether you are eligible.